Comparative non-persistence in the first year of treatment with oral anticoagulants in patients with atrial fibrillation: A French comprehensive nationwide study

CONCLUSIONS: In this nationwide observational study, non-persistence rates of oral anticoagulant treatment were high in patients treated for NVAF. Apixaban-treated patients seem to experience lowest discontinuation rates 12 months after treatment initiation compared to patients treated with any other OAC.PMID:36257903 | DOI:10.1016/j.acvd.2022.06.006

Source: Archives of Cardiovascular Diseases - October 18, 2022 Category: Cardiology Authors: Nicolas Danchin Gabriel Steg Isabelle Mah é Olivier Hanon Flore Jacoud Ma ëva Nolin Faustine Dalon Fran çois-Emery Cotte Sabrina Gollety Eric Van Ganse Manon Belhassen Source Type: research